SNP Analysis in 16S rRNA for Rapid Microbial Classification

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for microbial classification and quantitation are not sensitive, specific, rapid, or cost-effective, and often require complex and costly procedures, particularly in diagnosing sepsis, which can lead to inappropriate antibiotic use and increased healthcare costs due to inefficiencies in detecting and differentiating between Gram-positive and Gram-negative bacteria.

Innovation Solution

The use of single nucleotide polymorphisms (SNPs) in 16S rRNA genes to identify and classify bacteria as Gram-positive or Gram-negative, allowing for rapid differentiation and quantitation of microorganisms in samples, including those from patients with suspected sepsis, using methods that analyze nucleic acid for specific SNPs at defined positions in the 16S rRNA gene.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If traditional phenotypic or chemotypic classification methods are used, then the classification can be performed with simple procedures, but the sensitivity and specificity are insufficient and the process is not rapid

Engineering Contradiction:
Improveclassification sensitivity and specificityVSAvoidprocedure complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The invention changes the detection parameter from phenotypic/chemotypic characteristics to genotypic characteristics by analyzing specific SNP positions in 16S rRNA genes. This allows simultaneous achievement of high sensitivity/specificity through genetic marker detection while maintaining relatively simple PCR-based procedures

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The invention replaces complex phenotypic classification procedures (staining, growth requirement testing, biochemical reactions) with a molecular biology approach using PCR amplification and SNP detection. This substitution achieves higher precision while actually simplifying the overall workflow through automation potential

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

2Measurement precision

If genotypic classification methods are used, then sensitivity, specificity, and automation capability are improved, but the cost and procedural complexity increase

Engineering Contradiction:
Improveclassification sensitivity and specificityVSAvoidcost-effectiveness
Core Design Contradiction:
Measurement precisionVSEase of manufacture

Solution Approach 1:

The invention segments the 16S rRNA gene into specific hypervariable regions (V1-V9) and further identifies specific SNP positions within these regions that differentiate Gram-positive and Gram-negative bacteria. By targeting only these specific segmented regions rather than entire genes or whole-genome sequencing, the method achieves high precision at reduced cost

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The invention changes from analyzing entire 16S rRNA sequences or multiple genetic markers to analyzing only specific SNP positions (e.g., positions 396 and 398) within hypervariable regions. This parameter change from comprehensive sequencing to targeted SNP detection significantly reduces cost while maintaining high classification accuracy

Inventive Principle:
Principle #35Parameter changes

3Measurement precision

If current microbial detection methods are used for sepsis diagnosis, then the procedures can be performed with existing technology, but the speed and accuracy of differentiation between Gram-positive and Gram-negative bacteria are insufficient

Engineering Contradiction:
Improvedifferentiation accuracyVSAvoiddiagnosis time
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

The invention performs preliminary identification of Gram status by detecting specific SNP patterns in 16S rRNA genes before initiating full microbial identification protocols or antibiotic treatment decisions. This preliminary action based on conserved genetic markers provides rapid Gram classification that guides subsequent diagnostic steps, reducing overall diagnosis time while maintaining accuracy

Inventive Principle:
Principle #10Preliminary action

Data Source

PatentEP3004386B1Microbial markers and uses therefor
Publication Date: 2019.08.07 IMMUNEXPRESS
  • EP3004386B1 patent drawingFigure 1
  • EP3004386B1 patent drawing
  • EP3004386B1 patent drawing

AI summary

Disclosed are methods for identifying and/or classifying microbes using one or more single nucleotide polymorphisms (SNPs) in 16S ribosomal RNA (16S rRNA) of prokaryotes and/or one or more SNPs in 5.8S ribosomal RNA (5.8S rRNA) of eukaryotes. Also disclosed are probes, primers and kits that are useful in those methods. Methods for the diagnosis of sepsis based upon these SNPs are also disclosed.